Regulatory T Cells Genetically Modified for the Lymphotoxin Alpha Gene and Uses Thereof
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 2 of these applications claim priority to application PCT/EP2018/081078, filed Nov 13, 2018. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Patent lifetimeUsedRemaining | Confidence |
|---|---|---|---|---|---|---|
| US 12,325,735 | Regulatory T Cells Genetically Modified for the Lymphotoxin Alpha Gene and Uses Thereof Inserm (Institut National de la Sante et de la Recherche Medicale), Universite d'Aix-Marseille and Centre National de la Recherche Scientifique (CNRS) In force · Medium confidence UsedRemaining | Inserm (Institut National de la Sante et de la Recherche Medicale), Universite d'Aix-Marseille and Centre National de la Recherche Scientifique (CNRS) | In force | Medium confidence | ||
| US 11,618,884 | Regulatory T Cells Genetically Modified for the Lymphotoxin Alpha Gene and Uses Thereof Inserm (Institut National de la Sante et de la Recherche Medicale), Universite d'Aix Marseille and Centre National de la Recherche Scientifique (CNRS) In force · High confidence | Inserm (Institut National de la Sante et de la Recherche Medicale), Universite d'Aix Marseille and Centre National de la Recherche Scientifique (CNRS) | In force | High confidence |
2 of 2 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.